Do you want to read an article? Please log in or register.
Extracorporeal membrane oxygenation as a bridge to lung transplantation: 5-year outcomes and bridge to decision in a large, older cohort
Further Publications
RECOMMENDED
Related content
RECOMMENDED
Further Publications
Basiliximab Induction Immunosuppression and Lung Transplant Outcomes: Propensity Analysis in a Multicenter Cohort
★ 1
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
J Heart Lung Transplant
Rim JG, Hellkamp AS, Neely ML, Reynolds JM, Belperio JA, Budev M, Eason L, Frankel CW, Keshavjee S, Kirchner J, Singer LG, Shah PD, Snyder LD, Samuel Weigt S, Palmer SM, Todd JL
doi: 10.1016/j.healun.2024.11.033
RECOMMENDED
Lung Cancer
Tumor Immunophenotypic Correlates in Patients Aged 80 Years or Older With Non-Small Cell Lung Cancer and Outcomes to First-Line Pembrolizumab in PD-L1 High (≥50%) Patients
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Clin Lung Cancer
Barrichello APC, Elkrief A, Ricciuti B, Ganta T, Marron TU, Wang X, Lotter W, Lindsay J, Santo V, Cortellini A, Sharma B, Felt K, Pfaff K, Lamberti G, Pecci F, Federico AD, Makarem M, Gandhi MM, Nguyen T, Haradon D, Vaz VR, Johnson BE, Debnath N, Wang Y, Kuang AG, Saeed A, Radford M, Lovly CM, Nebhan CA, Pinato DJ, Rodig SJ, Schoenfeld AJ, Awad MM, Alessi JV, Naqash AR
doi: 10.1016/j.cllc.2025.01.014
RECOMMENDED
Lung Cancer
Cemiplimab Monotherapy for First-Line Treatment of Patients with Advanced NSCLC with PD-L1 Expression ≥50%: 5-Year Outcomes of EMPOWER-Lung 1
★ 1
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
J Thorac Oncol
Kilickap S, Baramidze A, Sezer A, Özgüroğlu M, Gumus M, Bondarenko I, Gogishvili M, Nechaeva M, Schenker M, Cicin I, Fuang HG, Kulyaba Y, Zyuhal K, Scheusan RI, Garassino MC, Li Y, Zhu C, Kaul M, Perez J, Seebach F, Lowy I, Pouliot JF, Kim E, Magnan H
doi: 10.1016/j.jtho.2025.03.033
RECOMMENDED
Further Publications
Single Versus Double Lung Transplant in Older Adults: A Propensity-Matched Analysis
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 2
Recommended by
Dr Marcus Hesse, Faculty Member
Chest
Weingarten N, Mehta AC, Budev M, Ahmad U, Yun J, McCurry K, Elgharably H
doi: 10.1016/j.chest.2024.08.044
ARDS
Long-Term Health-Related Quality of Life Following Survival of Acute Respiratory Distress Syndrome and Extracorporeal Membrane Oxygenation Due to COVID-19
J Clin Med
Hermann M, Filipsky R, Bukowski N, Gerger G, Hermann A, Krenn K, Teufel A, Kimberger O, Laxar D, Maleczek M, Schaden E, Wiegele M, Willschke H, Tiboldi A
doi: 10.3390/jcm14103358
Pulmonary Fibrosis
Impact of availability of a highly effective Cystic Fibrosis treatment (elexacaftor/tezacaftor/ivacaftor) on lung transplant waitlist and lung transplantation trends in the US
Respir Med
Merlo C, Geiger JM, Wang Z, Lyden GR, Schladt DP, McGarry L
doi: 10.1016/j.rmed.2025.108171
RECOMMENDED
Further Publications
Comparing right- versus left-first implantation in off-pump sequential double-lung transplantation: an observational cohort study
★ 1
Recommended by
Dr Martin Frey, Faculty Member
Eur J Cardiothorac Surg
Van Slambrouck J, Decaluwé H, Vanluyten C, Vandervelde CM, Orlitová M, Beeckmans H, Schoenaers C, Jin X, Makarian RS, De Leyn P, Van Veer H, Depypere L, Belmans A, Vanaudenaerde BM, Vos R, Van Raemdonck D, Ceulemans LJ
doi: 10.1093/ejcts/ezae331
Pulmonary Fibrosis
Donor age over 55 is associated with worse outcome in lung transplant recipients with idiopathic pulmonary fibrosis
BMC Pulm Med
Moneke I, Ogutur ED, Kornyeva A, Fähndrich S, Schibilsky D, Bierbaum S, Czerny M, Stolz D, Passlick B, Jungraithmayr W, Frye BC
doi: 10.1186/s12890-024-03317-x
ARDS
Extracorporeal Membrane Oxygenation in the Management of Tumor Lysis Syndrome in Children: A Review of Cases
J Clin Med
Aidynbek Z, Kakenov E, Mironova O, Ydyrysheva K, Li T, Sazonov V
doi: 10.3390/jcm14082771